TRAIL及其受体在PCOS病人卵巢颗粒细胞表达(5)
[21]DUFOUR F, RATTIER T, CONSTANTINESCU A A, et al. Molecular mechanisms of TRAILinduced apoptosis of cancer cells[J]. Chinese Science Bulletin, 2001,8(9):707709.
[22]張娟,朱桂金,王昕荣,等. Apoptosis and expression of protein TRAIL in granulosa cells of rats with polycystic ovarian syndrome[J]. Journal of Huazhong University of Science and TechnologyMedical Sciences, 2007,27(3):311314.
[23]RULL K, TOMBERG K, KK K K, et al. Human soluble TRAIL protein inducing apoptosis in osteosarcoma cell[J]. Wuhan University Journal of Natural Sciences, 2007,34(6):11481152.
[24]BARAKONYI A, MIKO E, SZEREDAY L, et al. Cell death mechanisms and potentially cytotoxic natural immune cells in human pregnancies complicated by preeclampsia[J]. Reproductive Sciences (Thousand Oaks, Calif.), 2014,21(2):155166.
[HJ2mm]
[25]CARTLAND S P, HARITH H H, GENNER S W, et al. Nonalcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice[J]. Scientific Reports, 2017,7(1):18981907.
[26]HARPER E, FORDE H, DAVENPORT C, et al. Vascular calcification in type2 diabetes and cardiovascular disease: integrative roles for OPG, RANKL and TRAIL[J]. Vascular Pharmacology, 2016,82:3040
[27]PASARIN M, ABRALDES J G, LIGUORI E et al. Intrahepatic vascular changes in nonalcoholic fatty liver disease: potential role of insulinresistance and, 百拇医药(李科 祁秀娟 吕映频 谭慧芳 苗佳)
[22]張娟,朱桂金,王昕荣,等. Apoptosis and expression of protein TRAIL in granulosa cells of rats with polycystic ovarian syndrome[J]. Journal of Huazhong University of Science and TechnologyMedical Sciences, 2007,27(3):311314.
[23]RULL K, TOMBERG K, KK K K, et al. Human soluble TRAIL protein inducing apoptosis in osteosarcoma cell[J]. Wuhan University Journal of Natural Sciences, 2007,34(6):11481152.
[24]BARAKONYI A, MIKO E, SZEREDAY L, et al. Cell death mechanisms and potentially cytotoxic natural immune cells in human pregnancies complicated by preeclampsia[J]. Reproductive Sciences (Thousand Oaks, Calif.), 2014,21(2):155166.
[HJ2mm]
[25]CARTLAND S P, HARITH H H, GENNER S W, et al. Nonalcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice[J]. Scientific Reports, 2017,7(1):18981907.
[26]HARPER E, FORDE H, DAVENPORT C, et al. Vascular calcification in type2 diabetes and cardiovascular disease: integrative roles for OPG, RANKL and TRAIL[J]. Vascular Pharmacology, 2016,82:3040
[27]PASARIN M, ABRALDES J G, LIGUORI E et al. Intrahepatic vascular changes in nonalcoholic fatty liver disease: potential role of insulinresistance and, 百拇医药(李科 祁秀娟 吕映频 谭慧芳 苗佳)